Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition--The Dream of Translational Medicine
ContributorsUppugunduri Satyanarayana, Chakradhara Rao
Published inJournal of Cardiovascular Pharmacology, vol. 67, no. 2, p. 191-192
Publication date2016
Keywords
- Animals
- Antibodies, Monoclonal/pharmacology/therapeutic use
- Humans
- Hypercholesterolemia/drug therapy
- Proprotein Convertase 9/antagonists & inhibitors/metabolism
- Proprotein Convertases/antagonists & inhibitors/metabolism
- Translational Medical Research/methods/trends
Affiliation entities
Research groups
Citation (ISO format)
UPPUGUNDURI SATYANARAYANA, Chakradhara Rao, GEORGE, Melvin. Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition--The Dream of Translational Medicine. In: Journal of Cardiovascular Pharmacology, 2016, vol. 67, n° 2, p. 191–192. doi: 10.1097/FJC.0000000000000324
Main files (1)
Article (Published version)
Identifiers
- PID : unige:96547
- DOI : 10.1097/FJC.0000000000000324
- PMID : 26398165
Journal ISSN0160-2446
